Lista de obras -

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

artículo científico publicado en 2015

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

scientific article published on 27 November 2018

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

artículo científico publicado en 2016

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

scientific article published on 05 November 2018

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients

artículo científico publicado en 2016

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

artículo científico publicado en 2018

Advances in clinical trial design for development of new TB treatments: A call for innovation

article

Advances in clinical trial design: Weaving tomorrow's TB treatments

scientific article published on 27 February 2020

Advances in the diagnosis and treatment of tuberculosis.

artículo científico publicado en 2006

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

artículo científico publicado en 2012

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

artículo científico publicado en 2018

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

artículo científico publicado en 2014

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

artículo científico publicado en 2017

Challenges in the clinical assessment of novel tuberculosis drugs.

artículo científico publicado en 2016

Childhood tuberculosis in northern Viet Nam: a review of 103 cases

artículo científico publicado en 2014

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

artículo científico publicado en 2017

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

artículo científico publicado en 2009

Clinical practice. Latent tuberculosis infection

artículo científico publicado en 2002

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

artículo científico publicado en 2015

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

artículo científico publicado en 2017

Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.

artículo científico publicado en 2008

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS

artículo científico publicado en 2014

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

scientific article published on 06 September 2019

Discriminating between latent and active tuberculosis with multiple biomarker responses.

artículo científico publicado en 2011

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

artículo científico publicado en 2018

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

artículo científico publicado en 2016

Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment ⬇️

artículo científico publicado el 18 de abril de 2013

Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam.

artículo científico publicado en 2015

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

artículo científico publicado en 2016

Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.

artículo científico publicado en 2013

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

artículo científico publicado en 2011

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

scientific article published on 30 May 2019

First in vivo magnetic particle imaging of lung perfusion in rats.

artículo científico publicado en 2017

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

artículo científico publicado en 2014

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

artículo científico publicado en 2017

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis

artículo científico publicado en 2012

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

artículo científico publicado en 2015

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

artículo científico publicado en 2018

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

artículo científico publicado en 2019

Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection

artículo científico publicado en 2019

Multidrug-resistant tuberculosis - Authors' reply

artículo científico publicado en 2019

Mycobacterium tuberculosis lineage--what's in your lungs?

artículo científico publicado en 2012

Non-tuberculous mycobacterial infections at San Francisco General Hospital.

artículo científico publicado en 2014

Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis

artículo científico publicado en 2010

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

artículo científico publicado en 2016

Prevention of tuberculosis in HIV-infected patients.

artículo científico publicado en 2006

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

artículo científico publicado en 2017

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

scientific article published on 01 January 2019

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California

artículo científico publicado en 2014

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study ⬇️

artículo científico publicado el 1 de agosto de 2011

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

artículo científico publicado en 2008

Reply to: "ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-resistant TB: A Two-edged Sword?"

artículo científico publicado en 2020

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum.

artículo científico publicado en 2017

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

artículo científico publicado en 2019

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

artículo científico publicado en 2015

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

artículo científico publicado en 2010

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis

scientific article published on 28 May 2020

Target regimen profiles for treatment of tuberculosis: a WHO document.

artículo científico publicado en 2017

The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients

artículo científico publicado en 2018

The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis

scientific article published on 20 March 2020

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

artículo científico publicado en 2017

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

scientific article published on 10 December 2019

Towards tuberculosis elimination: an action framework for low-incidence countries

artículo científico publicado en 2015

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

artículo científico publicado en 2017

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

artículo científico publicado en 2015

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

artículo científico publicado en 2019

Treatment of Drug-Susceptible Tuberculosis.

artículo científico publicado en 2016

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

artículo científico publicado en 2016

Treatment outcomes of patients with HIV and tuberculosis.

artículo científico publicado en 2007

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

artículo científico publicado en 2016

Update in tuberculosis and nontuberculous mycobacterial disease 2011.

artículo científico

Update in tuberculosis and nontuberculous mycobacterial disease 2012.

artículo científico

Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea

artículo científico publicado en 2016

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure

artículo científico publicado en 2016

Lista de obras de

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.

Advances in clinical trial design for development of new TB treatments: A call for innovation

Advances in clinical trial design: Weaving tomorrow's TB treatments

Advances in the diagnosis and treatment of tuberculosis.

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

Challenges in the clinical assessment of novel tuberculosis drugs.

Childhood tuberculosis in northern Viet Nam: a review of 103 cases

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Clinical practice. Latent tuberculosis infection

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

Discriminating between latent and active tuberculosis with multiple biomarker responses.

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment ⬇️

Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

First in vivo magnetic particle imaging of lung perfusion in rats.

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection

Multidrug-resistant tuberculosis - Authors' reply

Mycobacterium tuberculosis lineage--what's in your lungs?

Non-tuberculous mycobacterial infections at San Francisco General Hospital.

Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Prevention of tuberculosis in HIV-infected patients.

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study ⬇️

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

Reply to: "ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-resistant TB: A Two-edged Sword?"

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum.

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis

Target regimen profiles for treatment of tuberculosis: a WHO document.

The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients

The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

Towards tuberculosis elimination: an action framework for low-incidence countries

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Treatment of Drug-Susceptible Tuberculosis.

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

Treatment outcomes of patients with HIV and tuberculosis.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Update in tuberculosis and nontuberculous mycobacterial disease 2011.

Update in tuberculosis and nontuberculous mycobacterial disease 2012.

Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure